• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. THE INTERFERON{alpha}/{beta} RECEPTOR PROVIDES PROTECTION AGAINST INFLUENZA VIRUS REPLICATION BUT IS DISPENSABLE FOR INFLAMMATORY RESPONSE SI

Giuseppe

Emeritus
J Virol. 2009 Nov 25. [Epub ahead of print]

THE INTERFERON{alpha}/{beta} RECEPTOR PROVIDES PROTECTION AGAINST INFLUENZA VIRUS REPLICATION BUT IS DISPENSABLE FOR INFLAMMATORY RESPONSE SIGNALING.

Goodman AG, Zeng H, Proll SC, Peng X, Cilloniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG. - Department of Microbiology, University of Washington, Washington National Primate Research Center, Seattle, WA 98195; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30333.

The innate immune response provides the first line of defense against foreign pathogens by responding to molecules which are a signature of a pathogenic infection. Certain RNA viruses, such as influenza virus, produce double-stranded RNA as an intermediate during the replication life cycle which activates pathogen-recognition receptors capable of inducing interferon production. By engaging interferon receptors, interferon activates the JAK-STAT pathway and results in positive feedback of interferon production, amplifying the response to viral infection. To examine how deficiencies in interferon signaling affect the cellular response to infection, we performed influenza virus infections in mouse embryonic fibroblasts lacking the interferon-alpha/beta receptor, the interferon-gamma receptor, or both. In the absence of the interferon-alpha/beta receptor, we observed increased viral replication but decreased activation of PKR, Stat1, and NF-kappaB; the presence or absence of the interferon-gamma receptor did not exhibit discernable differences of these readouts. Analysis of gene expression profiles showed that while cells lacking the interferon-alpha/beta receptor exhibited decreased transcription of antiviral genes, genes related to inflammatory and apoptotic responses were transcribed to similar levels as cells containing the receptor. These results indicate that while the interferon-alpha/beta receptor is needed to curb viral replication, it is dispensable for the induction of certain inflammatory and apoptotic genes. We have identified potential pathways, via IRF3 activation, or Hoxa13, Polr2a, Nr4a1, or Ing1 induction, that contribute to this redundancy. This study illustrates another way in which the host has evolved to establish several overlapping mechanisms to respond to viral infections.

PMID: 19939913 [PubMed - as supplied by publisher]
-
------
 
Back
Top Bottom